⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 12, 2024

[Evaluation of the efficacy of urine-based lipoarabinomannan antigen test in the diagnosis of pulmonary tuberculosis].

Tianhong Zhang Z C Ma R M Liu Yuanyuan Shang Jeffrey P. Lüdemann Ming Han Yu Pang

View Full Paper

Ask AI

Bookmark

Share

Abstract

To analyze the diagnostic efficacy of urinary lipoarabinomannan (LAM) antigen detection method in tuberculosis patients, and to provide an experimental basis for the clinical application of urinary LAM kit in China.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhang et al. (2024) studied this question.

synapsesocial.com/papers/68e79844b6db643587708e09 https://doi.org/10.3760/cma.j.cn112147-20230814-00074

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Quantitative Analysis of a Urine-Based Assay for Detection of Lipoarabinomannan in Patients with TuberculosisDiagnostic Study · 2010 · 82 citations
2Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art reviewDiagnostic Study · 2012 · 242 citations
3Advancements in LAM-based diagnostic kit for tuberculosis detection: enhancing TB diagnosis in HIV-negative individuals2024 · 14 citations
4Value of urinary lipoarabinomannan levels for tuberculosis diagnosis and monitoring of therapy2025
5Lateral flow urine lipoarabinomannan assay for tuberculosis diagnosis in HIV-positive inpatients and outpatients2025 · 2 citations